Nasal Decongestant Pe And Pain Relief Tablet
NDC Package 67091-209-24

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Nasal Decongestant Pe And Pain Relief (acetaminophen, phenylephrine hcl) tablets is do not use more than directedadults and children 12 years and over:take 2 caplets every 4 hoursdo not take more than 10 caplets in 24 hourschildren under 12 years: ask a doctor . This formulation utilizes a tablet delivery system. Marketed by Winco Foods, Llc, this product is identified by NDC 67091-209 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
67091-209-24
Package Description
2 BLISTER PACK in 1 CARTON / 12 TABLET in 1 BLISTER PACK
Product Code
67091-209
11-Digit Billing Format
67091020924
RxNorm Crosswalk
  • RxCUI: 1046378 - acetaminophen 325 MG / phenylephrine HCl 5 MG Oral Tablet
  • RxCUI: 1046378 - acetaminophen 325 MG / phenylephrine hydrochloride 5 MG Oral Tablet
  • RxCUI: 1046378 - APAP 325 MG / phenylephrine hydrochloride 5 MG Oral Tablet

Clinical Specifications

Proprietary Name
Nasal Decongestant Pe And Pain Relief Maximum Strength
Non-Proprietary Name
Acetaminophen, Phenylephrine Hcl
Substance Name
Acetaminophen; Phenylephrine Hydrochloride
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Do not use more than directedadults and children 12 years and over:take 2 caplets every 4 hoursdo not take more than 10 caplets in 24 hourschildren under 12 years: ask a doctor 

Regulatory & Marketing

Labeler Name
Winco Foods, Llc
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-23-2005
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67091-209-24 identifies a specific commercial package of 2 blister pack in 1 carton / 12 tablet in 1 blister pack of Nasal Decongestant Pe And Pain Relief Maximum Strength, a human over the counter drug labeled by Winco Foods, Llc. This tablet is formulated for oral use and contains acetaminophen; phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Winco Foods, Llc on June 23, 2005. The current certification is valid through December 31, 2027.

How is this Winco Foods, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67091020924. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
67091-209-24
11-Digit CMS (5-4-2)
67091-0209-24

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.